SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
BARR PHARMACEUTICALS INC
(NYSE:BRL Last Sale: )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NYSE: (BRL : $)
Employs 1,900.
Drugs SubIndustry up .00% / Health Industry up .00% Today
400 Chestnut Ridge Road Research Report Earnings Snapshot - Last
Woodcliff Lake, NJ 07677 Fact Sheet
Phone: 201-930-3300 Financial Statements
Peer Comparison
Annual Reports

B.L. Downey, Chmn./CEO, P.M. Bisaro, Pres./COO, William T. McKee, CFO
Acquired by TEVA PHARMACEUTICAL INDUSTRIES (Q:TEVA) December 23, 2008. Holders received 0.6272 TEVA or $39.90 cash per BRL. Independent developer, manufacturer and marketer of generic pharmaceuticals. Agreed to Acquire Croatia's Pliva for $2.2 billion cash, topping a rival proposal from Iceland's Actavis Group, June 27, 2006, then raised offer to $2.3 billion, 743 kuna ($129.05) per share, plus a 12 kuna ($2.08) dividend, a total of 755 kuna ($131.14) per share, June 29, 2006. Formerly, BARR LABORATORIES INC.
Historical Charts    Technical Analysis
No Historical Data available for BRL

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common BRL $ $ 0 $ $ 0 $37.4 $68.35 109,446
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock

A753
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex